The American pharmaceutical company Moderna announced Monday that new data showed its coronavirus vaccine to be remarkably effective at combating the infection, and that it would seek authorization from the FDA and European regulators to allow emergency use. The company’s CEO told the New York Times that shots could be available to high-risk populations as soon as December 21.
Those likely to get the early shots include those with medical problems, medical workers and the elderly. Younger people and the rest of the populations around the world will concentrate on a vaccine that simply kills the virus and liberates the victims.
Watch this website.